Outcomes of patients with heart failure in Türkiye

dc.authoridhttps://orcid.org/0000-0003-3416-5965
dc.authoridhttps://orcid.org/0000-0002-8169-8628
dc.authoridhttps://orcid.org/0000-0002-9417-7610
dc.authoridhttps://orcid.org/0000-0002-2227-6177
dc.authoridhttps://orcid.org/0000-0003-0224-1433
dc.authoridhttps://orcid.org/0000-0002-7828-9487
dc.authoridhttps://orcid.org/0000-0002-9798-9796
dc.authoridhttps://orcid.org/0000-0001-7552-8967
dc.authoridhttps://orcid.org/0000-0002-4027-9873
dc.authoridhttps://orcid.org/0000-0002-3935-0222
dc.authoridhttps://orcid.org/0000-0002-7068-1599
dc.authoridhttps://orcid.org/0000-0001-6947-2821
dc.authoridhttps://orcid.org/0000-0003-0825-1851
dc.authoridhttps://orcid.org/0000-0001-8104-6198
dc.contributor.authorŞahin, Anıl
dc.contributor.authorYilmaz, Mehmet Birhan
dc.contributor.authorÇelik, Ahmet
dc.contributor.authorÇöllüoğlu, İnci Tuğçe
dc.contributor.authorUral, Dilek
dc.contributor.authorAsarcikli, Lale Dinç
dc.contributor.authorNalbantgil, Sanem
dc.contributor.authorDemir, Emre
dc.contributor.authorÇavuşoğlu, Yüksel
dc.contributor.authorMurat, Selda
dc.contributor.authorKanik, Emine Arzu
dc.contributor.authorAta, Naim
dc.date.accessioned2025-03-03T08:35:49Z
dc.date.available2025-03-03T08:35:49Z
dc.date.issued2024-06-14
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractBackground/aim: Despite Türkiye’s relatively young population, there is an emerging trend of earlier diagnoses of chronic diseases, including heart failure (HF). This study aims to shed light on survival rates, potential influences of guideline-directed therapies, and sex-based differences necessitating personalized management in HF. Materials and methods: We conducted a nationwide retrospective cohort analysis of 2,722,151 patients with HF using deidentified data from the Turkish Ministry of Health’s national electronic database. That cohort included 2,701,099 adult patients with HF. Adult patients were divided into two groups based on their outcomes as those who were deceased and those who survived and were then compared. Multivariate regression analysis was conducted to identify variables predicting mortality. The patients’ hospital admissions and length of hospital stay were analyzed based on survival status and age. Results: Out of 2,722,151 HF patients, the overall mortality rate was 33.7%, with a difference observed according to sex (32.5% in female patients, 35.0% in male patients). Survival rates at 1, 5, and 7 years after the HF diagnosis were detailed. Deceased HF patients had more comorbidities, higher natriuretic peptides, and lower glomerular filtration rates. Hospitalization patterns varied, with 41% experiencing no hospitalization. The average length of hospital stay in 2022 was 6 days, with sex-and age-specific disparities. Conclusion: The survival rate of HF in Türkiye is similar to world data. The survival of female patients is better than that of male patients. Increased survival rates can likely be attributed to the widespread use of guideline-directed therapies. Finally, high healthcare utilization is observed, especially in emergency situations.
dc.identifier10.55730/1300-0144.5935
dc.identifier.citationŞahin, A., Yilmaz, M. B., Çelik, A., Çöllüoğlu, İ. T., Ural, D., Asarcikli, L. D., Nalbantgil, S., Demir, E., Çavuşoğlu, Y., Murat, S., Kanik, E. A., Ata, N., Ülgü, M. M., & Birinci, Ş. (2024). Outcomes of patients with heart failure in Türkiye. Turkish journal of medical sciences, 54(7), 1488–1496. https://doi.org/10.55730/1300-0144.5935
dc.identifier.doi10.55730/1300-0144.5935
dc.identifier.endpage1496
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue7
dc.identifier.pmid39735482
dc.identifier.scopus2-s2.0-85213392394
dc.identifier.scopusqualityQ1
dc.identifier.startpage1488
dc.identifier.urihttps://doi.org/10.55730/1300-0144.5935
dc.identifier.urihttps://hdl.handle.net/20.500.14619/15100
dc.identifier.volume54
dc.identifier.wosWOS:001381273000009
dc.identifier.wosqualityQ2
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherTUBITAK
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.ispartofseriesTurkish Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHeart failure
dc.subjectlength of stay
dc.subjectmortality
dc.subjectsex
dc.titleOutcomes of patients with heart failure in Türkiye
dc.typeArticle
oaire.citation.issue7
oaire.citation.volume54

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: